菌体治疗传递方法和临床试验用于对抗临床相关的病原体
Heba Mohammed Refat M Selim1,2, Fatma Alzahraa M Gomaa3, Mohammad Y Alshahrani4
1Department of Pharmaceutical Sciences, Faculty of Pharmacy, AlMaarefa University, Riyadh, Saudi Arabia.
Therapeutic delivery
|November 15, 2024
概括
菌体疗法为抗生素提供了一种有效的替代品,用于对抗多药耐药 (MDR) 细菌感染. 这篇评论强调了菌体治疗的重点.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 生物技术是生物技术.
背景情况:
- 多药耐药 (MDR) 细菌的增加对全球健康构成了重大挑战.
- 现有的抗微生物药物因广泛的耐药性而面临局限性.
- 菌体治疗正在成为治疗MDR感染的有希望的替代方案.
研究的目的:
- 审查MDR感染的菌体治疗的最新进展.
- 探索菌体攻击策略,配方和施用途径.
- 讨论临床试验状态,挑战和菌体治疗的未来前景.
主要方法:
- 对菌体治疗的体外和体内研究的文献综述.
- 对用于菌体治疗的当前临床试验数据的分析.
- 合成关于菌体机制,传递和监管障碍的信息.
主要成果:
- 菌体治疗显示出对MDR细菌具有显著的杀菌和抗生物膜活性.
- 目前正在研究各种菌体配方和施用途径的有效性和安全性.
- 一些菌体治疗候选者正在进行针对各种感染的临床试验.
结论:
- 菌体疗法显示出作为MDR感染的安全有效治疗的巨大潜力.
- 克服菌体疗法开发和临床实施方面的挑战对于其广泛采用至关重要.
- 持续的研究和临床评估对于充分实现菌体的治疗前景至关重要.
相关概念视频
Lytic Cycle of Bacteriophages
70.4K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.4K
Microorganisms in Medicine and Therapeutics
1
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1
Lysogenic Cycle of Bacteriophages
61.9K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
61.9K
Viral Replication: Lysogenic Cycle
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
Viral Replication: Lytic Cycle
1
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
1
Biological Methods for Microbial Control
2
Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
2


